Nader E, Romana M, Guillot N, Fort R, Stauffer E, Lemonne N, et al
These thresholds were chosen to ensure consistency in patient selection and comparability with previous reports
Erythromycin antagonises the deceleration of gastric emptying by glucagon-like peptide 1 (GLP-1) and unmasks its insulinotropic effect in healthy subjects
Upon administration, they enhance insulin secretion, inhibit glucagon release, and slow gastric emptying, which leads to reduced appetite and increased feelings of fullness
To view a copy of this licence, visit About this article Cite this article Krishnan, A., Schneider, C.V., Hadi, Y